de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevate behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons80449

Müller,  Marianne B.
AG Müller, Marianne, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80563

Uhr,  Manfred
AG Uhr, Manfred, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80464

Ohl,  Frauke
Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80556

Toschi,  Nicola
AG Landgraf, Rainer, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80372

Holsboer,  Florian
Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80418

Landgraf,  Rainer
AG Landgraf, Rainer, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Keck, M. E., Welt, T., Müller, M. B., Uhr, M., Ohl, F., Wigger, A., et al. (2003). Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevate behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology, 28(2), 235-243.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-9F45-4
Abstract
There is no abstract available